GlaxoSmithKline (GSK) agrees to acquire Human Genome Sciences (HGSI) for $3.6B, or $14.25 a...

|About: GlaxoSmithKline (GSK)|By:, SA News Editor

GlaxoSmithKline (GSK) agrees to acquire Human Genome Sciences (HGSI) for $3.6B, or $14.25 a share. HGSI shares +3%. (PR)